Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how

被引：13

作者：

Ribera, Josep-Maria ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Dept Clin Hematol, ICO Hosp Germany Trias & Pujol, Josep Carreras Leukemia Res Inst, Barcelona, Spain

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 08期

关键词：

MINIMAL-RESIDUAL DISEASE; 1ST COMPLETE REMISSION; REDUCED-INTENSITY; HIGH-RISK; THERAPY IMPROVES; EUROPEAN GROUP; CORD BLOOD; IMATINIB; CHEMOTHERAPY; RELAPSE;

D O I：

10.3324/haematol.2011.048348

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1083 / U10

页数：5

共 47 条

[1] Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease [J].

Arnold, R ;

Massenkeil, G ;

Bornhäuser, M ;

Ehninger, G ;

Beelen, DW ;

Fauser, AA ;

Hegenbart, U ;

Hertenstein, B ;

Ho, AD ;

Knauf, W ;

Kolb, HJ ;

Kolbe, K ;

Sayer, HG ;

Schwerdtfeger, R ;

Wandt, H ;

Hoelzer, D .

LEUKEMIA, 2002, 16 (12) :2423-2428

[2] Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation [J].

Bachanova, Veronika ;

Verneris, Michael R. ;

DeFor, Todd ;

Brunstein, Claudio G. ;

Weisdorf, Daniel J. .

BLOOD, 2009, 113 (13) :2902-2905

[3] Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study [J].

Baker, K. S. ;

Ness, K. K. ;

Weisdorf, D. ;

Francisco, L. ;

Sun, C-L ;

Forman, S. ;

Bhatia, S. .

LEUKEMIA, 2010, 24 (12) :2039-2047

[4] Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07. [J].

Bassan, Renato ;

Intermesoli, Tamara ;

Masciulli, Arianna ;

Rossi, Giuseppe ;

Pogliani, Enrico Maria ;

Spinelli, Orietta ;

Lambertenghi-Deliliers, Giorgio ;

Audisio, Ernesta ;

Mattei, Daniele ;

Ciceri, Fabio ;

Cassibba, Vincenzo ;

Romani, Claudio ;

Di Bona, Eros ;

Levis, Alessandro ;

Tosi, Manuela ;

Peruta, Barbara ;

Parolini, Margherita ;

Borlenghi, Erika ;

Fumagalli, Monica ;

Delaini, Federica ;

Marfisi, Rosa Maria ;

Oldani, Elena ;

Marchioli, Roberto ;

Rambaldi, Alessandro .

BLOOD, 2010, 116 (21) :881-881

[5] Modern Therapy of Acute Lymphoblastic Leukemia [J].

Bassan, Renato ;

Hoelzer, Dieter .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) :532-543

[6] Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) [J].

Bassan, Renato ;

Spinelli, Orietta ;

Oldani, Elena ;

Intermesoli, Tamara ;

Tosi, Manuela ;

Peruta, Barbara ;

Rossi, Giuseppe ;

Borlenghi, Erika ;

Pogliani, Enrico M. ;

Terruzzi, Elisabetta ;

Fabris, Pietro ;

Cassibba, Vincenzo ;

Lambertenghi-Deliliers, Giorgio ;

Cortelezzi, Agostino ;

Bosi, Alberto ;

Gianfaldoni, Giacomo ;

Ciceri, Fabio ;

Bernardi, Massimo ;

Gallamini, Andrea ;

Mattei, Daniele ;

Di Bona, Eros ;

Romani, Claudio ;

Scattolin, Anna Maria ;

Barbui, Tiziano ;

Rambaldi, Alessandro .

BLOOD, 2009, 113 (18) :4153-4162

[7] Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008 [J].

Brueggemann, M. ;

Schrauder, A. ;

Raff, T. ;

Pfeifer, H. ;

Dworzak, M. ;

Ottmann, O. G. ;

Asnafi, V. ;

Baruchel, A. ;

Bassan, R. ;

Benoit, Y. ;

Biondi, A. ;

Cave, H. ;

Dombret, H. ;

Fielding, A. K. ;

Foa, R. ;

Goekbuget, N. ;

Goldstone, A. H. ;

Goulden, N. ;

Henze, G. ;

Hoelzer, D. ;

Janka-Schaub, G. E. ;

Macintyre, E. A. ;

Pieters, R. ;

Rambaldi, A. ;

Ribera, J-M ;

Schmiegelow, K. ;

Spinelli, O. ;

Stary, J. ;

von Stackelberg, A. ;

Kneba, M. ;

Schrappe, M. ;

van Dongen, J. J. M. .

LEUKEMIA, 2010, 24 (03) :521-535

[8] Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia [J].

Brüggemann, M ;

Raff, T ;

Flohr, T ;

Gökbuget, N ;

Nakao, M ;

Droese, J ;

Lüschen, S ;

Pott, C ;

Ritgen, M ;

Scheuring, U ;

Horst, HA ;

Thiel, E ;

Hoelzer, D ;

Bartram, CR ;

Kneba, M .

BLOOD, 2006, 107 (03) :1116-1123

[9] Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival [J].

Burke, M. J. ;

Trotz, B. ;

Luo, X. ;

Baker, K. S. ;

Weisdorf, D. J. ;

Wagner, J. E. ;

Verneris, M. R. .

BONE MARROW TRANSPLANTATION, 2009, 43 (02) :107-113

[10] Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis [J].

Eapen, Mary ;

Rocha, Vanderson ;

Sanz, Guillermo ;

Scaradavou, Andromachi ;

Zhang, Mei-Jie ;

Arcese, William ;

Sirvent, Anne ;

Champlin, Richard E. ;

Chao, Nelson ;

Gee, Adrian P. ;

Isola, Luis ;

Laughlin, Mary J. ;

Marks, David I. ;

Nabhan, Samir ;

Ruggeri, Annalisa ;

Soiffer, Robert ;

Horowitz, Mary M. ;

Gluckman, Eliane ;

Wagner, John E. .

LANCET ONCOLOGY, 2010, 11 (07) :653-660

← 1 2 3 4 5 →